Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dazostinag Alone and in Combination With Pembrolizumab in Advanced Solid Tumors
NCT04420884Phase 2Completed
- Sponsor
- Takeda
- Start
- Jul 2020
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of dazostinag in solid tumor, head and neck squamous cell carcinoma (HNSCC), colorectal cancer (CRC), sponsored by Takeda. Started Jul 2020; status: completed.
02
Drugs
dazostinag
03
Conditions
solid tumorhead and neck squamous cell carcinoma (HNSCC)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT04420884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04420884.